UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	October 2, 2020

Accession Number:
Submission Type:
CIK: 0001228627 Company Name: REXAHN PHARMACEUTICALS, INC. File Number: 333-239702